The following companies are expected to report earnings after
hours on 03/12/2013. Visit our
Earnings Calendar
for a full list of expected earnings releases.
Kennedy-Wilson Holdings Inc.
(
KW
) is reporting for the quarter ending December 31, 2012. The real
estate company's consensus earnings per share forecast from the 3
analysts that follow the stock is $-0.08. This value represents a
-161.54% decrease compared to the same quarter last year. Zacks
Investment Research reports that the 2012 Price to Earnings ratio
for KW is -53.38 vs. an industry ratio of 10.90.
Dole Food Company, Inc
(
DOLE
) is reporting for the quarter ending December 31, 2012. The food
company's consensus earnings per share forecast from the 4 analysts
that follow the stock is $-0.01. This value represents a -50.00%
decrease compared to the same quarter last year. Zacks Investment
Research reports that the 2012 Price to Earnings ratio for DOLE is
12.40 vs. an industry ratio of 20.10.
ACADIA Pharmaceuticals Inc.
(
ACAD
) is reporting for the quarter ending December 31, 2012. The
biomedical (gene) company's consensus earnings per share forecast
from the 5 analysts that follow the stock is $-0.08. This value
represents a -20.00% decrease compared to the same quarter last
year. ACAD missed the consensus earnings per share in the 1st
calendar quarter of 2012 by -9.09%. Zacks Investment Research
reports that the 2012 Price to Earnings ratio for ACAD is -18.51
vs. an industry ratio of -11.40.
Global Cash Access Holdings, Inc.
(
GCA
) is reporting for the quarter ending December 31, 2012. The
financial services company's consensus earnings per share forecast
from the 3 analysts that follow the stock is $0.16. This value
represents a 14.29% increase compared to the same quarter last
year. GCA missed the consensus earnings per share in the 1st
calendar quarter of 2012 by -4.76%. Zacks Investment Research
reports that the 2012 Price to Earnings ratio for GCA is 8.57 vs.
an industry ratio of 22.40.
GenMark Diagnostics, Inc.
(
GNMK
) is reporting for the quarter ending December 31, 2012. The
medical instruments company's consensus earnings per share forecast
from the 3 analysts that follow the stock is $-0.23. This value
represents a -14.81% decrease compared to the same quarter last
year. GNMK missed the consensus earnings per share in the 4th
calendar quarter of 2011 by -3.85%. The "days to cover" for this
stock exceeds 22 days. Zacks Investment Research reports that the
2012 Price to Earnings ratio for GNMK is -11.87 vs. an industry
ratio of 121.50.
Avid Technology, Inc.
(
AVID
) is reporting for the quarter ending December 31, 2012. The
computer software company's consensus earnings per share forecast
from the 2 analysts that follow the stock is $0.11. This value
represents a -63.33% decrease compared to the same quarter last
year. Zacks Investment Research reports that the 2012 Price to
Earnings ratio for AVID is -15.44 vs. an industry ratio of 17.40.
Whitestone REIT
(
WSR
) is reporting for the quarter ending December 31, 2012. The reit
company's consensus earnings per share forecast from the 3 analysts
that follow the stock is $0.25. This value represents a no change
for the same quarter last year. Zacks Investment Research reports
that the 2012 Price to Earnings ratio for WSR is 16.23 vs. an
industry ratio of 16.30.
Kratos Defense & Security Solutions, Inc.
(
KTOS
) is reporting for the quarter ending December 31, 2012. The
aerospace and defense company's consensus earnings per share
forecast from the 7 analysts that follow the stock is $-0.05. This
value represents a -129.41% decrease compared to the same quarter
last year. In the past year KTOS has beat the expectations every
quarter. The highest one was in the 3rd calendar quarter where they
beat the consensus by 550%. The "days to cover" for this stock
exceeds 22 days. Zacks Investment Research reports that the 2012
Price to Earnings ratio for KTOS is -7.86 vs. an industry ratio of
37.60.
Geron Corporation
(
GERN
) is reporting for the quarter ending December 31, 2012. The
biomedical (gene) company's consensus earnings per share forecast
from the 4 analysts that follow the stock is $-0.14. This value
represents a -36.36% decrease compared to the same quarter last
year. GERN missed the consensus earnings per share in the 4th
calendar quarter of 2011 by -10%. Zacks Investment Research reports
that the 2012 Price to Earnings ratio for GERN is -2.59 vs. an
industry ratio of -11.40, implying that they will have a higher
earnings growth than their competitors in the same industry.
AcelRx Pharmaceuticals, Inc.
(
ACRX
) is reporting for the quarter ending December 31, 2012. The drug
company's consensus earnings per share forecast from the 3 analysts
that follow the stock is $-0.39. This value represents a 18.18%
increase compared to the same quarter last year. Zacks Investment
Research reports that the 2012 Price to Earnings ratio for ACRX is
-3.41 vs. an industry ratio of 10.00.
Amicus Therapeutics, Inc.
(
FOLD
) is reporting for the quarter ending December 31, 2012. The
biomedical (gene) company's consensus earnings per share forecast
from the 5 analysts that follow the stock is $-0.36. This value
represents a -256.52% decrease compared to the same quarter last
year. FOLD missed the consensus earnings per share in the 3rd
calendar quarter of 2012 by -45.83%. Zacks Investment Research
reports that the 2012 Price to Earnings ratio for FOLD is -2.40 vs.
an industry ratio of -11.40, implying that they will have a higher
earnings growth than their competitors in the same industry.
GAIN Capital Holdings, Inc.
(
GCAP
) is reporting for the quarter ending December 31, 2012. The
investment bankers company's consensus earnings per share forecast
from the 2 analysts that follow the stock is $0.05. This value
represents a -200.00% decrease compared to the same quarter last
year. The "days to cover" for this stock exceeds 12 days.The days
to cover, as reported in the 2/28/2013 12:00:00 AM short interest
update, increased214.28660386096 from previous report on2/15/2013
12:00:00 AM Zacks Investment Research reports that the 2012 Price
to Earnings ratio for GCAP is 14.41 vs. an industry ratio of 14.00,
implying that they will have a higher earnings growth than their
competitors in the same industry.